By API User
HIGHLIGHTS FY24 glaucoma segment sales up 37% to US$15.3 million compared to pcp FY24 USA Sales up 73% to US$11.4 million compared to pcp 2H FY24 USA Sales up 77% compared to pcp Fourth consecutive half-year of revenue growth in the USA Additional sales specialists recruited in the USA, materially improving geographic coverage Material improvement in glaucoma … Continued
By API User
DUBAI, United Arab Emirates, July 07, 2024 (GLOBE NEWSWIRE) — At DP World’s Aviv Clinics Dubai, the world’s most advanced brain and body performance clinic, we understand the heartache parents feel when their child’s development is hindered by conditions like cerebral palsy, autism spectrum disorder, traumatic brain injury, and other neurological conditions. Watching a child … Continued
By API User
VALENCIA, Spain and BRUSSELS, July 03, 2024 (GLOBE NEWSWIRE) — Seeking alternatives to obtain oocytes without ovarian stimulation is a pioneering line of research in reproductive medicine. The inconveniences that the process of ovarian stimulation can generate are a current barrier for some women and couples who are considering starting a reproductive treatment. In fact, … Continued
By API User
Highlights Initial pre-submission meeting held with the U.S. Food & Drug Administration (FDA) where CLEO outlined its submission framework and clinical plan Positive feedback from FDA provides confidence in CLEO’s U.S. regulatory strategy Clinical trial design receives Institutional Review Board (IRB) approval in both U.S. and Australia MELBOURNE, AUSTRALIA, 26 June 2024: Ovarian cancer diagnostics … Continued
By API User
Fully automated diagnostic techniques, including liquid handling robots, are poised to improve the lives of millions of people living with inflammatory diseases worldwide. A landmark WEHI study has revealed new methods in detecting necroptosis, a key factor in many inflammatory diseases like psoriasis, arthritis and inflammatory bowel disease. The findings mark a … Continued
By API User
Results of the first clinical trial of Australia’s ‘second generation’ bionic eye have demonstrated ‘substantial improvement’ in four participants’ functional vision, daily activities and quality of life over a period of more than two and a half years. Detailed outcomes from the trial, led by the Centre for Eye Research Australia, Bionics Institute, University of … Continued
By API User
Official Results Powerball Draw no. 1463 Draw Date: Thursday, 30 May 2024 Drawn Numbers Winning Numbers 35 2 3 33 20 22 10 (drawn order) Powerball 9 … Continued
By API User
LUXEMBOURG / ACCESSWIRE / May 30, 2024 / Moolec Science SA (NASDAQ:MLEC) a science-based food ingredient company focused on producing animal proteins in plants through Molecular Farming technology, announced today its Business Update for the third quarter of Fiscal Year 2024 ended March 31, 2024. Moolec Science Logo The main highlights of Moolec’s business update … Continued
By API User
The research of BioMed X team EPD – Early Intervention in Psychiatric Diseases – has shed light on the molecular mechanisms underlying white matter deficits in schizophrenia. HEIDELBERG, GERMANY / ACCESSWIRE / May 28, 2024 / German independent research institute BioMed X announces the successful completion of its second neuroscience project in partnership with Boehringer … Continued
By API User
Scientia Professor Matthew Kiernan AM CEO at Neuroscience Research Australia has been elected as a 2024 Fellow of the Australian Academy of Science, joining the ranks of the nation’s most distinguished scientists. This honour recognises Professor Kiernan’s outstanding contributions to new approaches in the treatment of neurodegenerative diseases. Professor Kiernan is an internationally renowned expert in … Continued
